Posts

Showing posts with the label prostate cancer

Repurposed Antiparasitic Agents and Integrative Interventions in Advanced Prostate Cancer Following Standard Therapy Failure: A Critical Review (2026)

Prostate Cancer in 2026: Risk Modification, Therapeutic Advances, and Emerging Evidence from Repurposed Drug Case Series

In Silico Evaluation of Ivermectin, Mebendazole, Metformin, High-Dose Vitamin C, Hyperthermia and More for Stage 4 Prostate Cancer (2025): A Simulated Randomized Controlled Trial